[1]
LampropoulouD. I., “The potential role of the combined PARP-1 and VEGF inhibition in severe SARS-CoV-2 (COVID-19) infection”, J Infect Dev Ctries, vol. 16, no. 01, pp. 101-111, Jan. 2022.